INTRAVENOUS PAMIDRONATE FOR REFRACTORY LYMPHEDEMA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BEIGI A.A.; SADEGHI A.M.; MASOUDPOUR H.; SHIRAZINEJAD S.; MOTTAGHI P.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2011 | Volume:13 | Issue:4 Page(s): 263-266

Download Full-Text

View:

305

Download:

147

Cites:

Information Journal Paper

Title

INTRAVENOUS PAMIDRONATE FOR REFRACTORY LYMPHEDEMA

Author(s)

Keywords

BISPHOSPHONATE

PAMIDRONATE

REFRACTORY LYMPHEDEMA

Abstract

Background: Based on beneficial reports of PAMIDRONATE use for reflex sympathetic dystrophy in reduction of pain and swelling, this drug can be studied as a novel treatment for REFRACTORY LYMPHEDEMA. This study aims to determine the effectiveness of PAMIDRONATE on lymphedema and its possible side effects.Methods: Twelve cases of lower limb REFRACTORY LYMPHEDEMA were enrolled. They received intravenous PAMIDRONATE monthly for 3 consecutive months and were followed by measuring any discomfort with visual analog scale (VAS) and physician global assessment, based on objective signs of limb volume and circumference.Results: The limb volume, circumference, and satisfaction of the patients improved significantly.Conclusion: PAMIDRONATE when is added to conservative treatments may reduce lymphedema and improve the patient’s comfort.

Cites

No record.

References

No record.

Cite

APA: Copy

BEIGI, A.A., SADEGHI, A.M., MASOUDPOUR, H., SHIRAZINEJAD, S., & MOTTAGHI, P.. (2011). INTRAVENOUS PAMIDRONATE FOR REFRACTORY LYMPHEDEMA. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 13(4), 263-266. SID. https://sid.ir/paper/292354/en

Vancouver: Copy

BEIGI A.A., SADEGHI A.M., MASOUDPOUR H., SHIRAZINEJAD S., MOTTAGHI P.. INTRAVENOUS PAMIDRONATE FOR REFRACTORY LYMPHEDEMA. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2011;13(4):263-266. Available from: https://sid.ir/paper/292354/en

IEEE: Copy

A.A. BEIGI, A.M. SADEGHI, H. MASOUDPOUR, S. SHIRAZINEJAD, and P. MOTTAGHI, “INTRAVENOUS PAMIDRONATE FOR REFRACTORY LYMPHEDEMA,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 13, no. 4, pp. 263–266, 2011, [Online]. Available: https://sid.ir/paper/292354/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops